Details for New Drug Application (NDA): 040312
✉ Email this page to a colleague
NDA 040312 describes INNOFEM, which is a drug marketed by Novo Nordisk Inc and is included in one NDA. Additional details are available on the INNOFEM profile page.
The generic ingredient in INNOFEM is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
The generic ingredient in INNOFEM is estradiol. There are seventy-five drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.
Summary for 040312
| Tradename: | INNOFEM |
| Applicant: | Novo Nordisk Inc |
| Ingredient: | estradiol |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 040312
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 0.5MG | ||||
| Approval Date: | Nov 19, 1999 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 1MG | ||||
| Approval Date: | Nov 19, 1999 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 2MG | ||||
| Approval Date: | Nov 19, 1999 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
